Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-13

FDA Approved: DALFAMPRIDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for dalfampridine from Aurobindo Pharma Limited, indicating an approval action for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)